Ex post facto drug management system is ineffective under new drug plan

Pharmaceutical business sources say that if a new drug price re-evaluation system is firmly established next year, the existing ex post facto drug management system, which has been regularly implemented four times a year, is indeed ineffective in that the new system may cover the price-adjustment process by more than more than 80% every year.

Business sources further note that any necessity ...